Last reviewed · How we verify

NCT04793451: PSYCHENDOFIT

Endurance-strength Training in Obese Women

Completed NA Last updated 11 March 2021
What this trial tests

NA trial testing Endurance training in Obesity in 38 participants. Completed in 30 December 2017.

Timeline
6 December 2012
Primary endpoint
1 December 2017
30 December 2017

Quick facts

Lead sponsorPoznan University of Medical Sciences
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposebasic science
Enrollment38
Start date6 December 2012
Primary completion1 December 2017
Estimated completion30 December 2017
Sites1 location across Poland

Drugs / interventions tested

Conditions studied

Sponsor

Poznan University of Medical Sciences

Who can join

Adults 18 to 65, female only, with Obesity or Cognitive Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to compare the effects of three months' endurance training and three months' endurance-strength training on selected psychological aspects in women with abdominal obesity.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Type of Physical Training and Selected Aspects of Psychological Functioning of Women with Obesity: A Randomised Trial.
    Bąk-Sosnowska M, Gruszczyńska M, Skrypnik D, Grzegorczyn S, et al · · 2021 · cited 8× · PMID 34444714 · DOI 10.3390/nu13082555

Verify or expand the search:

Other trials of Endurance training

Trials testing the same drug.

Other recruiting trials for Obesity

Currently open trials in the same condition.

Other Poznan University of Medical Sciences trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04793451.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing